CoChat

The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression

Open access
van Rooij, Sanne J. H., Riva-Posse, Patricio, McDonald, William M. · 2020 · Current Treatment Options in Psychiatry
Cited by 38

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Purpose of Review In this review, the efficacy and safety of FDA-approved neuromodulation devices (electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and vagus nerve stimulation (VNS)), as well as emerging neuromodulation treatments currently under investigation. Recent Findings ECT is the “gold standard” somatic therapy for treatment-resistant depression (TRD). Although the clinical benefits are outweighed by potential cognitive and cardiovascular side effects in a majority of cases, it remains unfairly stigmatized. TMS has few cognitive or somatic side effects but is not as effective as the treatment of psychotic depression or more treatment-resistant depression in elders. VNS has limited data in older patients but has been shown to be effective in chronic, treatment-resistant adults. Several investigative neuromodulation treatments including magnetic seizure therapy (MST), focal electrically administered seizure therapy (FEAST), transcutaneous VNS (tVNS), transcranial direct current stimulation (tDCS), and deep brain simulation (DBS) shown promise in geriatric TRD. Summary ECT, TMS, and VNS are effective treatments for late-life depression, and research has continued to refine the techniques. Investigative neuromodulation techniques are promising, but evidence for the safety and efficacy of these devices in the geriatric population is needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40501-020-00216-w

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 38

Metadata

Authors
van Rooij, S. J. H., Riva-Posse, P., & McDonald, W. M.
Venue
Current Treatment Options in Psychiatry
Published
2020-06-03
Volume
7
Issue
3
Pages
337-348
ISSN
2196-3061 (ISSN-L)
OpenAlex
W3033511398
Cited by
38
References
22
FWCI
2.55
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression. https://app.cochat.ai/papers/10.1007/s40501-020-00216-w
The paper
van Rooij, S. J. H., Riva-Posse, P., & McDonald, W. M. (2020). The Efficacy and Safety of Neuromodulation Treatments in Late-Life Depression. Current Treatment Options in Psychiatry. https://doi.org/10.1007/s40501-020-00216-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.